According to a report published by Grand View Research, Inc., the global cell culture market is estimated to reach a valuation of around USD 37.0 billion by 2022.
Increasing scope for protein production, vaccine research and development, and biopharmaceutical development can propel the market during the forecast period (2012 to 2022). In addition, growing number of cancer research projects and applications based on gene therapy can also drive the market in the coming years.
Development of 3D cell culture techniques is expected to augment the market over the forecast period. It is extensively adopted in biopharmaceuticals and vaccine development. Rising development of proteomic gene expression is also anticipated to boost the demand for 3D cell culture technique in the coming years. In addition, rapid advancements and growing adoption of integrated robotic liquid handling laboratory automation culture systems are projected to provide a fillip to the market. These systems offer enhanced capacity handling, high efficiency, and better reproducible purity levels.
Moreover, high prevalence of chronic diseases is encouraging studies and research related to cell biology and cytology, which is leading to increased popularity of cell culture. Various advanced technologies are being used to develop and culture tissues from cells that can be used in grafting and surgical therapies based on personalized genomics and proteomics. Stem cell therapy research is gaining traction, which can be effective to treat various diseases. Increasing support and funding for stem cell therapy is also likely to open up tremendous growth opportunities for the market.
Full Research Report On Cell Culture Market Analysis: https://www.grandviewresearch.com/industry-analysis/cell-culture-market
The cell culture market can be segmented on the basis of consumables, product, applications, and regions. Based on consumables, the market can be categorized into media, sera, and reagents. In terms of application, the market can be classified into biopharmaceuticals, drug development, cancer research, gene therapy, toxicity testing, tissue culture and engineering, and vaccine production. On the basis of product, the market can be fragmented into culture systems, centrifuges, biosafety equipment, incubators, pipetting instruments, and cryostorage equipment.
Geographically, the market can be divided into North America, Europe, Asia Pacific, and RoW. In 2014, North America was the leading revenue contributor in the market. Influx of biopharmaceuticals over the past few years has worked in favor of the regional market. There are a high number of research and development projects based on cytological investigation for drug and vaccine development, genomics, and proteomics in the region. It also represents one of the leading markets for cell culture consumables and instruments. Factors such as innovations in animal-component free media and availability of advanced automated cell culture system that can improve production capacity and reduce lag times are estimated to contribute to the growth of the North America market over the forecast period.
View More Reports Of This Category By Grand View Research At: https://www.grandviewresearch.com/industry/biotechnology
Europe has exhibited significant growth in recent times due to spiraling demand for cell culture technology and cell biology research in the region. Companies domiciled in the region are also making investments in advanced technologies and advanced cell culture applications.
Asia Pacific is expected to register noteworthy growth during the forecast period due to burgeoning demand for cell culture media and increasing biopharmaceutical research. Increasing supportive initiatives and investments by governments are supplementing the growth of the regional market. Rising development and production of drugs, vaccine, and biologics is anticipated to trigger the growth of the market in APAC. Growing outsourcing and contract manufacturing of cell culture technology in the region is projected to create more opportunities in the years to come.
Some of the key players operating in the market are Thermo Fisher Scientific, Dickinson & Company, Becton, Corning, and Sigma-Aldrich Co., LLC.
Market players are focusing more on research and development (R&D) of 3D cell culture. Participants are also planning to commercialize technologically advanced cell culture, which can provide greater accuracy of replication and high purity. In addition, many pharmaceutical companies are acquiring or collaborating with biotechnological firms to expand their product range and to create their presence in the market. Involvement of high cost and investment to build cell culture technology infrastructure is leading to growth in contract research and manufacturing business. Soaring demand for outsourcing and contract manufacturing is also likely to create more opportunities in the market.
Access Full Press Release Of This Report By Grand View Research: https://www.grandviewresearch.com/press-release/global-cell-culture-market
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: www.grandviewresearch.com
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.
Email: Send Email
Phone: 1-415-349-0058, Toll Free: 1-888-202-9519
Address:28 2nd Street, Suite 3036
City: San Francisco
Country: United States